What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Endocrinology
His scientific interests lie mostly in Internal medicine, Endocrinology, Ghrelin, Receptor and Orexigenic.
His Internal medicine study is mostly concerned with Insulin, Leptin, Hormone, Energy homeostasis and Hypothalamus.
His research is interdisciplinary, bridging the disciplines of Neuropeptide Y receptor and Endocrinology.
His work on Ghrelin O-acyltransferase and Ghrelin secretion as part of general Ghrelin research is often related to Growth hormone secretion, thus linking different fields of science.
His Receptor study integrates concerns from other disciplines, such as Lipid metabolism, Glucagon and Pharmacology.
His work carried out in the field of Orexigenic brings together such families of science as Growth hormone secretagogue, Fatty acid synthase, Appetite and Fatty acid metabolism.
His most cited work include:
- Ghrelin induces adiposity in rodents. (3432 citations)
- Circulating Ghrelin Levels Are Decreased in Human Obesity (1736 citations)
- The Distribution and Mechanism of Action of Ghrelin in the CNS Demonstrates a Novel Hypothalamic Circuit Regulating Energy Homeostasis (1343 citations)
What are the main themes of his work throughout his whole career to date?
Matthias H. Tschöp mainly focuses on Internal medicine, Endocrinology, Ghrelin, Receptor and Obesity.
Internal medicine is closely attributed to Diabetes mellitus in his study.
His study in Hormone, Insulin, Energy homeostasis, Leptin and Hypothalamus are all subfields of Endocrinology.
His work on Growth hormone secretagogue receptor as part of general Ghrelin research is frequently linked to Growth hormone secretion, bridging the gap between disciplines.
His studies deal with areas such as Signal transduction, Glucagon and Pharmacology as well as Receptor.
His study in Obesity is interdisciplinary in nature, drawing from both Body weight and Bioinformatics.
He most often published in these fields:
- Internal medicine (78.60%)
- Endocrinology (78.15%)
- Ghrelin (31.31%)
What were the highlights of his more recent work (between 2016-2021)?
- Endocrinology (78.15%)
- Internal medicine (78.60%)
- Diabetes mellitus (12.16%)
In recent papers he was focusing on the following fields of study:
Matthias H. Tschöp focuses on Endocrinology, Internal medicine, Diabetes mellitus, Obesity and Type 2 diabetes.
Matthias H. Tschöp regularly links together related areas like Receptor in his Endocrinology studies.
Internal medicine is represented through his Hypothalamus, Insulin, Glucose homeostasis, Homeostasis and Leptin research.
His Obesity research is multidisciplinary, incorporating elements of Incretin, Triglyceride and Bioinformatics.
In his study, Agonist and Ghrelin is inextricably linked to Pharmacology, which falls within the broad field of Type 2 diabetes.
His study looks at the relationship between Brown adipose tissue and topics such as Energy homeostasis, which overlap with Metabolic control analysis.
Between 2016 and 2021, his most popular works were:
- Animal models of obesity and diabetes mellitus (215 citations)
- Alternatively activated macrophages do not synthesize catecholamines or contribute to adipose tissue adaptive thermogenesis (188 citations)
- The Sustained Effects of a Dual GIP/GLP-1 Receptor Agonist, NNC0090-2746, in Patients with Type 2 Diabetes. (127 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Enzyme
His primary areas of study are Endocrinology, Internal medicine, Type 2 diabetes, Adipose tissue and Pharmacology.
His Endocrinology study focuses mostly on Energy homeostasis, Brown adipose tissue, Thermogenesis, Appetite and Hypothalamus.
Leptin, Ghrelin, Agonist, Receptor and Insulin resistance are subfields of Internal medicine in which his conducts study.
His Ghrelin research is mostly focused on the topic Growth hormone secretagogue receptor.
In his study, which falls under the umbrella issue of Type 2 diabetes, Bioinformatics is strongly linked to Glucagon.
His Pharmacology research integrates issues from Incretin and Endocrine system.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
